797 results on '"Boyle, Brendan"'
Search Results
152. Su1219 GUT MICROBIAL STRAINS AND METABOLITES IN DISEASE COURSE OF PEDIATRIC ULCERATIVE COLITIS
153. 1160 REAL-WORLD PEDIATRIC INFLIXIMAB PHARMACOKINETIC MODEL VERIFIES CRITICAL NEED FOR PRECISION DOSING SOFTWARE
154. Mo1892 PREDICTING SUB-OPTIMAL TRANSITIONS IN ADOLESCENTS WITH INFLAMMATORY BOWEL DISEASES
155. 1161 CLINICAL AND HOST BIOLOGICAL FACTORS CAN PREDICT COLECTOMY RISK IN CHILDREN NEWLY DIAGNOSED WITH ULCERATIVE COLITIS
156. Mo1903 HIGH RATES OF SURGERY PERSIST FOR CHILDREN PRESENTING WITH INTERNAL PENETRATING CROHN'S DISEASE: OBSERVATIONS FROM A MULTICENTER STUDY
157. 613 ANTIBODIES TO INFLIXIMAB ACCELERATE DRUG CLEARANCE WHILE INTENSIFICATION STRATEGIES REVERSE IMMUNOGENICITY AND RECAPTURE CLINICAL RESPONSE
158. Professional faultlines and interprofessional differentiation in multidisciplinary team innovation: The moderating role of inclusive leadership
159. 22 CHANGE IN FECAL CALPROTECTIN AND LACTOFERRIN PREDICT CLINICAL REMISSION FOLLOWING INDUCTION THERAPY WITH INFLIXIMAB IN PEDIATRIC CROHN’S DISEASE (CD)
160. Professional faultlines and interprofessional differentiation in multidisciplinary team innovation: The moderating role of inclusive leadership.
161. Additional file 1: of A study of macro-, meso- and micro-barriers and enablers affecting extended scopes of practice: the case of rural nurse practitioners in Australia
162. Achieving Target Infliximab Drug Concentrations Improves Blood and Fecal Neutrophil Biomarkers in Crohn's Disease.
163. Leadership coaching’s efficacy and effect mechanisms – a mixed-methods study
164. Managing Inclusiveness and Diversity in Teams: How Leader Inclusiveness Affects Performance through Status and Team Identity.
165. Predicting Suboptimal Transitions in Adolescents With Inflammatory Bowel Disease.
166. Understanding the Role of Profession in Multidisciplinary Team Innovation: Professional Identity, Minority Dissent and Team Innovation.
167. PREDICTORS OF PRIMARY NON-RESPONSE AND DRUG DURABILITY FOR ADALIMUMAB AND INFLIXIMAB IN PEDIATRIC INFLAMMATORY BOWEL DISEASE.
168. INFLIXIMAB MARKET SHARE AND ASSOCIATED COST SAVINGS FOLLOWING BIOSIMILAR MARKET ENTRY.
169. Abstract 900: Troponin I Tyrosine 26 Phosphorylation Accelerates i n vivo Myocardial Relaxation
170. Social Identification, Minority Dissent and Team Innovation
171. Challenges in IBD Research: Pragmatic Clinical Research
172. Su1790 – Infliximab Rescue Less Effective in Preventing Colectomy Early in the Course of Newly Diagnosed Ulcerative Colitis
173. 302 – Early Change in Fecal Calprotectin Predicts One Year Clinical Outcome in Children Newly Diagnosed with Ulcerative Colitis
174. 235 – Early Infliximab Pharmacokinetics and Week One Clinical Response in Pediatric Acute Severe Ulcerative Colitis: the Arch Study
175. Tu1760 – Alterations in Expression Quantitative Trait Loci from Diagnosis to Recovery in Pediatric Ulcerative Colitis
176. Tu1290 – Relationships Between Clinical Characteristics, Treatment, and Histological Remission in a Pediatric Eosinophilic Esophagitis Cohort
177. Tu1756 – The Treatment Naive Rectal Transcriptome Identifies Pathways Underlying Response to Induction Corticosteroid Therapy in Ulcerative Colitis
178. Mo1796 – Vedolizumab Experience in Children and Adolescents with Inflammatory Bowel Disease: A Multicenter Observational Study (VOLCANO)
179. A study of macro-, meso- and micro-barriers and enablers affecting extended scopes of practice: the case of rural nurse practitioners in Australia
180. Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study
181. International experience, attitudes toward women and the adoption of supportive HR practices
182. Troponin I Tyrosine Phosphorylation: Novel Regulator of Cardiac Function
183. Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response
184. Histologic Correlates of Clinical and Endoscopic Severity in Children Newly Diagnosed With Ulcerative Colitis
185. The transfer of HRM practices from emerging Indian IT MNEs to their subsidiaries in Australia: The MNE diamond model
186. Compositional and Temporal Changes in the Gut Microbiome of Pediatric Ulcerative Colitis Patients Are Linked to Disease Course
187. Comorbidities in Childhood Celiac Disease: A Phenome Wide Association Study Using the Electronic Health Record
188. Democratic values
189. Too many cooks in the kitchen? The contingent curvilinear effect of shared leadership on multidisciplinary healthcare team innovation.
190. Impacts of supportive HR practices and organisational climate on the attitudes of HR managers towards gender diversity – a mediated model approach.
191. Continued Statural Growth in Older Adolescents and Young Adults With Crohn's Disease and Ulcerative Colitis Beyond the Time of Expected Growth Plate Closure.
192. Contributors
193. Recapturing the spirit of Bretton Woods
194. Analysis of Using the Total White Blood Cell Count to Define Severe New-onset Ulcerative Colitis in Children.
195. Overcoming the challenge of "fuzzy" assessment and feedback.
196. RNA Sequence Analyses throughout the Course of Mouse Cardiac Laminopathy Identify Differentially Expressed Genes for Cell Cycle Control and Mitochondrial Function.
197. International experience, attitudes toward women and the adoption of supportive HR practices.
198. Improving Post-induction Antitumor Necrosis Factor Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease.
199. A Quality Improvement Approach to External Infliximab Infusions in Pediatric Inflammatory Bowel Disease.
200. Characterization of Stool Virome in Children Newly Diagnosed With Moderate to Severe Ulcerative Colitis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.